scholarly journals EFFECT OF CHRONIC KIDNEY DISEASE ON LEFT ATRIAL APPENDAGE OCCLUSION OUTCOME: A SINGLE-CENTRE RETROSPECTIVE ANALYSIS

2018 ◽  
Vol 71 (11) ◽  
pp. A302 ◽  
Author(s):  
Chak Yu So ◽  
Gary S.H. Cheung ◽  
Christy K.Y. Chan ◽  
Kelvin K.H. Kam ◽  
Anna K.Y. Chan ◽  
...  
Heart ◽  
2021 ◽  
pp. heartjnl-2021-319345
Author(s):  
Sae Morita ◽  
Aaqib H Malik ◽  
Toshiki Kuno ◽  
Tomo Ando ◽  
Risheek Kaul ◽  
...  

ObjectivePercutaneous left atrial appendage occlusion (LAAO) is an alternative strategy for prevention of thromboembolic events in patients with atrial fibrillation and unsuitable for long-term oral anticoagulation. The study aimed to evaluate the causes and timing of readmissions within 6 months following percutaneous LAAO in a real-world setting.MethodsWe conducted a retrospective cohort study of percutaneous LAAO performed in the USA between January and June of 2016–2018 using the Nationwide Readmissions Database.ResultsOverall, 12 446 patients who underwent LAAO were included in the analyses and 3477 patients (28%) were readmitted within 6 months following the interventions. Readmitted patients were more often women (p=0.001). The index hospitalisation was characterised by longer duration of hospital stay (p<0.001) and complicated with acute kidney injury (p<0.001) among readmitted patients compared with those without readmissions. Readmissions within 6 months following the index intervention were mainly due to heart failure (13%) and gastrointestinal bleeding (12%). Characteristics associated with readmissions due to heart failure included previously known heart failure (HR 2.39; 95% CI 1.70 to 3.37), valvular heart disease (HR 1.39; 95% CI 1.05 to 1.84) and chronic kidney disease (HR 1.42; 95% CI 1.03 to 1.94). Readmissions due to gastrointestinal bleeding were associated with diabetes mellitus (HR 1.78; 95% CI 1.25 to 2.53), chronic kidney disease (HR 1.86; 95% CI 1.23 to 2.81) and previous anaemia (HR 2.41; 95% CI 1.54 to 3.77).ConclusionsAfter percutaneous LAAO, over a quarter of the patients in the USA required rehospitalisation within 6 months, mainly due to heart failure and gastrointestinal bleeding.


2021 ◽  
Vol 25 (07) ◽  
pp. 273-278
Author(s):  
Boris Schmidt ◽  
Kyrill Rogacev

ZUSAMMENFASSUNGBedauerlicherweise existieren bisher keine randomisierten Studiendaten hinsichtlich des Stellenwerts eines Vorhofohrverschlusssystems (LAAC: „left atrial appendage closure“) im Vergleich zu oralen Antikoagulanzien (OAK) bei CKD-Patienten (CKD: „chronic kidney disease“). Eine derartige Studie (WATCH AFIB in CKD) wurde wegen geringer Rekrutierungszahlen eingestellt. Aus den im Beitrag angesprochenen Beobachtungsstudien kann allerdings eine gute Sicherheit und Effektivität der Therapie abgeleitet werden. In Anbetracht der unzureichenden Evidenz sollte bei VHF Patienten (VHF: Vorhofflimmern) mit CKD bis zu einer glomerulären Filtrationsrate (GFR) von 30 ml/min/1,73 m2 primär eine NOAK-Therapie (NOAK: neue OAK) verordnet werden. Im Falle von Blutungen kann dann gemäß Leitlinienempfehlung eine LAAC alternativ angeboten werden. Im Falle von Patienten mit dialysepflichtiger CKD muss eine individuelle Entscheidung getroffen werden, ob und wie eine Thromboembolieprophylaxe durchgeführt werden soll.


2021 ◽  
Vol 14 (16) ◽  
pp. 1830-1839 ◽  
Author(s):  
Keerat Rai Ahuja ◽  
Robert W. Ariss ◽  
Salik Nazir ◽  
Rohit Vyas ◽  
Anas M. Saad ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document